Dopamine Agonists: Their Role in the Treatment of Parkinson's Disease
JNNP 68;685-690, Brooks,D.J., 2000
Pleuropulmonary Disease Associated with Dopamine Agonist Therapy
Ann Neurol 30:613-616, Bhatt,M.H.,et al, 1991
Psychotic Reactions During Treatment of Pituitary Tumours with Dopamine Agonists
BMJ 289:1101-1103, Turner,T.H.,et al, 1984
Postpartum Cerebral Angiopathy with Intracerebral Hemorrhage in a Patient Receiving Lisuride
Neurol 50:1152-1154, Roh,J.K.&Park,K.S., 1998
Lisuride, A Dopamine Agonist in the Treatment of Early Parkinson's Disease
Neurol 39:336-339, Rinne,U.K., 1989
Lisuride Infusion Pump:A Device for the Treatment of Motor Fluctuations in Parkinson's Disease
Lancet 1:467-470, Obeso,J.A.,et al, 1986
Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
NEJM 313:656-659, Liuzzi,A.,et al, 1985
Bromocriptine & Lisuride in Parkinson Disease
Ann Neurol 13:44-47, Lieberman,A.N.,et al, 1983
Lisuride Versus Bromocriptine Treatment in Parkinson Disease:A Double-blind Study
Neurol 32:69-72, LeWitt,P.A.,et al, 1982
Lisuride in Parkinsonism
Neurol 31:371-376, Gopinathan,G.,et al, 1981
Lisuride in Parkinson Disease:Efficacy of Lisuride Compared to Levodopa
Neurol 31:961-965, Lieberman,A.N.,et al, 1981
Lisuride Combined with Levodopa in Advanced Parkinson Disease
Neurol 31:1466-1469, Lieberman,A.N.,et al, 1981